• We are catalysts for innovation, commercialising next-generation technologies developed by

    The University of Manchester’s world-class research base

    • £360m+ invested by venture funders

    • 40+ spin-out companies created

    • 7,500+ licences and IP partnerships concluded

    • 4,000+ invention disclosures received

    • £115m+ IP and R&D revenue generated for the University

  • We are catalysts for innovation, commercialising next-generation technologies developed by The University of Manchester’s world-class research base

    • £300m+ invested by venture funders since 2004

    • 40+ spin-out companies created

    • 4,800+

      licences and IP partnerships concluded

    • 3,700+ invention disclosures received

    • 1,300+ jobs generated across various industry sectors

    • £105m+ IP and R&D revenue generated for the University

Author Archive

UK University Technology Transfer: behind the headlines

The Technology Transfer Offices of Edinburgh, Imperial, Oxford, Cambridge, Manchester and UCL have collaborated to produce a briefing paper, “UK University Technology Transfer: behind the headlines”.

The document, explains the role and achievements of TTOs, and answers some frequently asked questions. It is intended to be a useful resource for government, industry and other sectors who interact with university TTOs.

While each university has its own structure and assignment of responsibilities, the goals of each TTO are broadly similar, and regulatory and procedural issues faced are common to all.

Click here for full article

CryoMan-SMR™ Heads to Gastech 14

The CryoMan-SMR™ team will be heading to the Gastech 14 conference and exhibition in Seoul, South Korea this week to promote its innovative and efficient gas liquefaction process.

Professionals, companies and various other interested parties within the natural gas and liquefied natural gas (LNG) industries flock to the event, which takes place every 18 months and which features a robust programme of papers and technical seminars.

The CryoMan-SMR™ consortium’s Simon Clarke from UMIP, The University of Manchester’s agent for Intellectual Property commercialisation, will be attending the four-day event, which runs from Monday March 24th to Thursday 27th.

“The Gastech Conference offers a great opportunity for CryoMan-SMR™, enabling us to present our process and technology to members of the entire LNG supply chain.”

“The 2012 London event was fantastic for the consortium, which managed to ignite the interest of a number of leading companies. One of these is currently carrying out an assessment of our proprietary process.”

“CryoMan-SMR™ is ideally placed to service an industry where increases in efficiency are so highly sought-after. Companies in the sector expend a great deal of time and effort on achieving modest improvements, so it’s no surprise that there’s such a great deal of interest in our approach – which can deliver significant productivity gains whilst retaining simplicity of design and construction. In many cases, it may be possible to retrofit CryoMan-SMR™ on to existing plant,” he said.

The Gastech Exhibition serves some of the industry’s most valuable decision-makers and buyers, providing an invaluable hub for organisations and individuals interested in networking and building strategic partnerships.

Similarly, its conference programme will see leading delegates from across the globe come together to discuss important industry issues, including the growing demand for gas and LNG in Asia, significant new commercial and technical opportunities, as well as a wealth of ground-breaking new project presentations.


Mentoring meets Biomed: Get involved!

Would you benefit from being able to discuss your challenges with an impartial industry insider and develop your own knowledge and skills? Or would others benefit from your wealth of experience?

The Greater Manchester Business Growth Hub is working in partnership with Bionow and other biomedical industry partners to offer access to industry insiders with expertise to help ambitious business people to achieve their growth ambitions.

Aimed at SMEs based in the North of England we are bringing together mentees and mentors through 1-2-1 professional mentoring relationships, which will offer fresh insight for innovative Biomedical businesses developing their management and leadership capabilities, hone their strategies and ultimately achieve business growth in this demanding sector.

Mentors will share their experience and expertise to enhance the mentees’ skills and knowledge, identifying relevant areas for development and providing an invaluable professional relationship.

Why not find out more by coming along to meet likeminded people at our launch event at Manchester Science park or attend one of our exclusive mentoring workshops. Numbers are limited so give us a call on 0161 359 3050 or email us at info@businessgrowthhub.com

The reason the Government is funding this programme is because all the evidence shows that companies who receive external advice are more likely to grow and according to research, on average they grow 50% more than SME’s who do not.

The Launch of the fully funded Mentoring meets Biomed programme, is taking place at Manchester Science Park this Thursday at 5pm, followed by the three induction dates. If you cannot make the Launch, please book straight onto one of the Induction events.

Here are the links to each of the events:

Launch on Thursday 13th March at 5pm


Induction on Tuesday 18th March at Daresbury.


Induction on Thursday 20th March at Manchester


Induction on Tuesday 25th at Liverpool.


You can Book a Place on each of the events pages, and if you are not already signed up to the Business Growth Hub, you can do it there and then, as you have to in order to go to any event.

The University of Manchester has been chosen to host a Johnson & Johnson Innovation partnering office at our campus-based Innovation Centre, UMIC.

J&JJohan Verbeeck, Senior Director of Partnership Management at Johnson & Johnson Innovation, will establish a regular presence at the University working with the Business Engagement Support Team.

Johnson & Johnson Innovation has four Innovation Centres based in Boston, California, London & Shanghai. The Innovation Centres aim to bring together experts from Johnson & Johnson with local innovators to facilitate exchange of ideas and provide the resources necessary to support translation of research. Through these innovation centres, Johnson & Johnson Innovation can interact more directly with life science “hot spots” across the country by launching regional partnering offices.

By being based at the University, Mr Verbeeck said he hoped to build strong personal relationships with leading scientists to facilitate collaboration across pharmaceutical, medical devices and diagnostics, and consumer sectors. He hopes this will lead to identification and investment in pre-clinical proof of concept innovations and, ultimately, accelerate the advancement of healthcare solutions and disease therapies.

Professor Paul Townsend, Associate Dean for Business Engagement, Faculty of Medical and Human Sciences, said: “The funding and collaboration arena in academia and biotech has changed dramatically over the recent past. This phenomenal opportunity of working with Johnson & Johnson and having them here in Manchester is a true win/win situation.”

The partnership is expected to bring about enhanced opportunities for collaboration and partnership building on the University’s existing relationship with Johnson & Johnson.